Pfizer Makes Renewed AstraZeneca Approach

Pfizer confirmed it made a renewed approach to AstraZeneca regarding a takeover valued at nearly $100 billion, but the U.K.-listed pharmaceutical firm had declined to engage in talks.

Leave a Reply

Your email address will not be published. Required fields are marked *